Phytopharmaceuticals: An emerging platform in modern medicine

International Conference and Exhibition on Marine Drugs and Natural Products

July 25-27, 2016 Melbourne, Australia

Dilip Ghosh

Soho Flordis International & NutriConnect, Australia

Keynote: J Pharmacogn Nat Prod

Abstract :

A comprehensive review is presented which shows the plant kingdom as an almost inexhaustible reservoir of potential drugs. The longstanding, successful use of herbal drug combinations in traditional medicine makes it necessary to find a rationale for the pharmacological and therapeutic superiority of many of them in comparison to isolated single constituents. As a result a new category, â�?�?Phytopharmaceuticalâ�? has emerged in several countries. There are many definitions but the core essence is â�?�?Phytopharmaceutical drug which includes purified and standardized fraction with defined minimum four bioactive or phytochemical compounds (qualitatively and quantitatively assessed) of an extract of a medicinal plant or its part, for internal or external use of human beings or animals for diagnosis, treatment, mitigation or prevention of any disease or disorder but does not include administration by parental routeâ�? (CDSCO, Govt. of India, 2016). In last decade, we have seen the sluggish growth of Herbal/Ayurvedic products and decrease in Pharma R&D output in terms of reduction in number of NCEs and increasing cost of new drug discovery. Current allopathic practice is unable to meet the unmet needs of multicomponent drug for multi target diseases. A number of problems, such as usefulness of RCTs in herbal medicine which are connected with the search for new prototype drugs of biological origin are also described. Special attention will be given on role of natural products in therapy; as biologically active compounds as such, as starting materials for (semi)synthetic drugs and, also as source of inspiration or as models for the synthesis of new drugs with better therapeutic, chemical or physical properties than the original compounds.

Biography :

Dilip Ghosh has received his PhD in Biomedical Science from University of Calcutta, India. Previously, he held positions in Organon (India) Ltd.; HortResearch, New Zealand; USDA-ARS, HNRCA at Tufts University, Boston; The Smart Foods Centre, & Neptune Bio-Innovation Pty. Ltd., Australia. He is an international speaker, facilitator and author. He is a fellow of American College of Nutrition, professional member of AIFST, and also he is the Editorial Board Member of several journals. He has published more than 70 papers in peer reviewed journals, numerous articles in food and nutrition magazines and 4 books under CRC Press, USA.

Email: dilip.ghosh@sfihealth.com